Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy

In view of the severe downsides of conventional cancer therapies, the quest of developing alternative strategies still remains of critical importance. In this regard, antigen cross-presentation, usually employed by dendritic cells (DCs), has been recognized as a potential solution to overcome the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Makandar, Amina I., Jain, Mannat, Yuba, Eiji, Sethi, Gautam, Gupta, Rajesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784904/
https://www.ncbi.nlm.nih.gov/pubmed/36560459
http://dx.doi.org/10.3390/vaccines10122049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784904/
https://www.ncbi.nlm.nih.gov/pubmed/36560459
http://dx.doi.org/10.3390/vaccines10122049

Ejemplares similares